Will single-time tumor profiling and a "guilt by association" approach allow us to outsmart HER2-positive breast cancer?

Carlos L. Arteaga

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1071-1073
Number of pages	3
Journal	Clinical Cancer Research
Volume	13
Issue number	4
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-2717
State	Published - Feb 15 2007

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-06-2717

Other files and links

Cite this

@article{24c9b6443d224a70b8eedfaa8b35bce5,

title = "Will single-time tumor profiling and a {"}guilt by association{"} approach allow us to outsmart HER2-positive breast cancer?",

author = "Arteaga, {Carlos L.}",

year = "2007",

month = feb,

day = "15",

doi = "10.1158/1078-0432.CCR-06-2717",

language = "English (US)",

volume = "13",

pages = "1071--1073",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "4",

}

TY - JOUR

T1 - Will single-time tumor profiling and a "guilt by association" approach allow us to outsmart HER2-positive breast cancer?

AU - Arteaga, Carlos L.

PY - 2007/2/15

Y1 - 2007/2/15

UR - http://www.scopus.com/inward/record.url?scp=33947280565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947280565&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-06-2717

DO - 10.1158/1078-0432.CCR-06-2717

M3 - Editorial

C2 - 17317812

AN - SCOPUS:33947280565

SN - 1078-0432

VL - 13

SP - 1071

EP - 1073

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 4

ER -